Trial Profile
Single-arm, open label, clinical trial of cabazitaxel to assess safety and efficacy in Japanese patients with castration resistant prostate cancer (CRPC) previously treated with a docetaxel-containing regimen
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 18 May 2016
Price :
$35
*
At a glance
- Drugs Cabazitaxel (Primary) ; Prednisolone
- Indications Prostate cancer
- Focus Adverse reactions; Therapeutic Use
- 20 Apr 2015 Status changed from active, no longer recruiting to completed, according to University Hospital Medical Information Network - Japan
- 17 Sep 2014 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan record.
- 22 Apr 2014 New trial record